The weight loss drug semaglutide showed significant cardiovascular benefits; Texas and Florida are restricting the promotion of COVID-19 vaccines; some Ohio legislators are seeking to block courts from interpreting the state’s recently passed constitutional amendment that created a right to abortion.
In an international study, the weight loss drug semaglutide (Wegovy) demonstrated a 20% reduction in serious heart problems among individuals with pre-existing heart disease, challenging the perception of obesity medications as purely cosmetic, according to the Associated Press. The research, spanning 17,500 participants across 41 countries, is the first to show that Wegovy not only aids weight loss but also prevents heart-related issues in individuals without diabetes. These findings may reshape treatment guidelines and increase pressure for health insurers to cover obesity medications.
Several US states, including Texas and Florida, are limiting public health departments' ability to promote COVID-19 vaccines, with rules forbidding advertising or recommending the vaccines, according to Kaiser Health News. This trend follows a political shift, with some Republican politicians reversing their positions on COVID-19 vaccines. As vaccine uptake remains low, public health officials fear dire consequences for health outcomes, emphasizing the impact of language changes and political interference on public health initiatives.
Several Ohio Republican lawmakers are advocating to limit the authority of courts to review cases related to the newly passed Issue 1 abortion amendment, claiming "foreign election interference" without evidence, according to The Hill. Issue 1, which passed with 57% of the vote, establishes a constitutional right to reproductive freedom while allowing restrictions after fetal viability. GOP legislators express concerns about the amendment's ambiguity and potential misuse, vowing to consider modifications through legislative channels rather than judicial interpretation.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen